Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Lipid biomarkers found in patients’ plasma

From: Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease

Before LIS vs. after LIS Before BBR plus LIS vs. after BBR plus LIS After LIS vs. after BBR plus LIS
LPC(20:4) LPC(18:2) PC(36:4)
LPC(22:6) LPC(20:4) PC(40:9)
LPI(20:4) LPC(20:5)  
PC(P-38:5) LPC(22:6)  
  LPI(20:4)  
  LPI(18:0)  
  1. Based on the criteria for the identification of the potential biomarkers, OPLS-DA analysis detected some biomarkers reflecting the therapeutic effect of berberine and lifestyle intervention